آخرین مطالب
امکانات وب
In outpatients with comorbidities and inpatients with nonsevere pneumonia, a combination of a beta-lactam or third-generation cephalosporin plus a macrolide, or monotherapy with a respiratory fluoroquinolone is recommended. Patients should be treated for methicillin-resistant Staphylococcus aureus or Pseudomonas infection only if they present with risk factors for those pathogens. All adults 65 years or older or those 19 to 64 with underlying conditions should receive the 20-valent pneumococcal conjugate vaccine alone or the 15-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine one year later. The 13-valent pneumococcal conjugate vaccine is no longer recommended for routine administration. The Centers for Disease Control and Prevention recommends vaccination against influenza and SARS-CoV-2 viruses for all adults.
Ryan Gorji MD
Dr Ryan Gorji
Ryan Gorji Chicago
#Ryan_Gorji_MD
#Dr_Ryan_Gorji
#Ryan_Gorji_Chicago
دانستنیهای پزشکی...
برچسب : نویسنده : ryangorji ryangorji بازدید : 129